Poster Session D - Tuesday Morning
Category: Liver
Blaine Massey, DO
Kirk Kerkorian School of Medicine at UNLV
Las Vegas, NV
Test | Pre-Treatment | Post-Treatment (2 months) | Reference Range |
Total bilirubin | 5.6 | 0.8 | 0.3-1.2 mg/dL |
Direct bilirubin | 2.8 | N/A | 0.0-0.2 mg/dL |
ALP | 1050 | 246 | 32-110 IU/L |
AST | 195 | 31 | 15-41 IU/L |
ALT | 442 | 58 | 15-63 IU/L |
GGT | 555 | 192 | 7-50 IU/L |
Albumin | 3.7 | 4.3 | 3.3-4.8 g/dL |
Platelets | 495 | 345 | 150-400 K/mcL |
INR/PT | 1.0/12.9 | N/A | 0.9-1.2/12.2- 14.4 seconds |
Syphilis Antibody EIA | Reactive | N/A | Nonreactive |
RPR Titer | 1:128 | N/A | Negative |
WBC | 8.9 | 4.8 | 4.8-10.8 K/mcL |
HIV | Nonreactive | Nonreactive | Nonreactive |
Anti-mitochondrial (M2) IgG | < 20.0 | N/A | Negative < 20 |
Anti-smooth muscle antibodies, total | Negative | N/A | Negative |
Hep A antibody, total | Reactive | N/A | Nonreactive |
Hep B surface antigen | Nonreactive | N/A | Nonreactive |
Hep B core antibody | Nonreactive | N/A | Nonreactive |
Hep B surface antibody | Reactive | N/A | Nonreactive |
Hep C antibody | Nonreactive | N/A | Nonreactive |